Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 5
2005 3
2006 3
2007 5
2009 5
2010 9
2011 4
2012 1
2013 2
2014 5
2015 3
2017 1
2018 3
2019 4
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Molecular and cellular biology of rhabdomyosarcoma.
De Giovanni C, Landuzzi L, Nicoletti G, Lollini PL, Nanni P. De Giovanni C, et al. Among authors: nicoletti g. Future Oncol. 2009 Nov;5(9):1449-75. doi: 10.2217/fon.09.97. Future Oncol. 2009. PMID: 19903072 Review.
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.
De Giovanni C, Landuzzi L, Palladini A, Ianzano ML, Nicoletti G, Ruzzi F, Amici A, Croci S, Nanni P, Lollini PL. De Giovanni C, et al. Among authors: nicoletti g. Cancers (Basel). 2019 Apr 11;11(4):517. doi: 10.3390/cancers11040517. Cancers (Basel). 2019. PMID: 30979001 Free PMC article.
Virus-like particle display of HER2 induces potent anti-cancer responses.
Palladini A, Thrane S, Janitzek CM, Pihl J, Clemmensen SB, de Jongh WA, Clausen TM, Nicoletti G, Landuzzi L, Penichet ML, Balboni T, Ianzano ML, Giusti V, Theander TG, Nielsen MA, Salanti A, Lollini PL, Nanni P, Sander AF. Palladini A, et al. Among authors: nicoletti g. Oncoimmunology. 2018 Jan 5;7(3):e1408749. doi: 10.1080/2162402X.2017.1408749. eCollection 2018. Oncoimmunology. 2018. PMID: 29399414 Free PMC article.
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft.
Landuzzi L, Palladini A, Ceccarelli C, Asioli S, Nicoletti G, Giusti V, Ruzzi F, Ianzano ML, Scalambra L, Laranga R, Balboni T, Arigoni M, Olivero M, Calogero RA, De Giovanni C, Dall'Ora M, Di Oto E, Santini D, Foschini MP, Cucchi MC, Zanotti S, Taffurelli M, Nanni P, Lollini PL. Landuzzi L, et al. Among authors: nicoletti g. Sci Rep. 2021 Jan 15;11(1):1563. doi: 10.1038/s41598-021-81085-y. Sci Rep. 2021. PMID: 33452364 Free PMC article.
60 results